Skip to content

Optimizing Prescribing of Antipsychotics in Long-Term Care

Optimizing Prescribing of Antipsychotics in Long-Term Care (OPAL): A Randomized Trial to Reduce Inappropriate Antipsychotic Prescribing in Long-Term Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03557593
Acronym
OPAL
Enrollment
Unknown
Registered
2018-06-15
Start date
2016-01-31
Completion date
2017-12-31
Last updated
2018-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia

Keywords

Antipsychotic, Nursing home, Long-term care

Brief summary

Inappropriate antipsychotic prescribing is a key quality indicator by which clinical outcomes might be monitored and improved in LTC. A multi component intervention to reduce inappropriate antipsychotic prescribing was evaluated in ten Canadian long-term care facilities.

Detailed description

Increasing numbers of older adults are affected by dementia, and many will eventually reside in long-term care (LTC), where antipsychotic use is relatively common. Inappropriate antipsychotic prescribing is a key quality indicator by which clinical outcomes might be monitored and improved in LTC but limited evidence exists on the most effective strategies for reducing inappropriate antipsychotic use. The objective of the study was to evaluate a multicomponent approach to reduce inappropriate prescribing of antipsychotics in LTC. A prospective, randomized stepped-wedge, study design was used to evaluate the effect of the intervention in 10 LTC facilities in Canada. The intervention consisted of an educational in-service, provision of evidence-based tools to assess and monitor neuropsychiatric symptoms (NPS) and monthly interprofessional team meetings.

Interventions

OTHEREducational

Multi component educational intervention in long-term care

Sponsors

Canadian Consortium on Neurodegeneration in Aging
CollaboratorOTHER
Canadian Frailty Network
CollaboratorOTHER
Queen's University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized, stepped-wedge cluster trial.

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of dementia * Receiving an antipsychotic medication without a diagnosis of psychosis

Exclusion criteria

* Diagnoses of schizophrenia, Huntington's disease * Presence of active hallucinations and/or delusions * Individuals at end of live or receiving palliative care

Design outcomes

Primary

MeasureTime frameDescription
Percentage of long-term care residents receiving any antipsychotic without a diagnosis of psychosis12-monthsThe proportion of long-term care residents receiving any antipsychotic without a diagnosis of psychosis is a quality indicator is used by the Canadian Institute for Health Information to determine potentially inappropriate antipsychotic use. The quality indicator is calculated using information routinely collected on Resident Assessment Index-Minimum Dataset (RAI-MDS) assessments by determining the number of individuals who received antipsychotics on one of more days in the 7 days preceding index (RAI-MDS item O4a ≥ 1). Individuals with schizophrenia, Huntington's disease, hallucinations, delusions, those with a limited life expectancy and those currently receiving palliative care are excluded from the numerator and denominator of this indicator.

Secondary

MeasureTime frameDescription
Worsening of behavioral symptoms12-monthsProportion of residents who had one or more of the following behavioural symptoms: wandering, physically or verbally abusive, or socially inappropriate behaviours) present on their target RAI-MDS assessment than on their prior assessment.
Use of physical restraints12-monthsProportion of residents in daily physical restraints as of the target RAI-MDS assessment.
Depression: Proportion of residents whose mood from symptoms of depression worsened12-monthsProportion of residents whose mood from symptoms of depression worsened compared to the previous RAI-MDS assessment.
Falls: Proportion of residents experiencing a fall in the 30 day12-monthsProportion of residents experiencing a fall in the 30 days preceding the RAI-MDS assessment.
Pain: Proportion of residents who had pain12-monthsProportion of residents who had pain on their target RAI=MDS assessment.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026